ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System

    A. Brar,1 D. Stefanov,3 R. Jindal,2 N. Sumrani,4 D. John,4 F. Tedla,1 M. Salifu.1

    1Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; 2Department of Surgery, Walter Reed National Military Medical Center, Uniformed Services University of Health Sciences, Bethesda, MD; 3Division of Research, SUNY Downstate School of Medicine, Brooklyn, NY; 4Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.

    Introduction: There is lack of information whether waitlisted dialysis patients with peripheral vascular disease (PVD) benefit from kidney transplantation.Methods: We used a cohort of USRDS…
  • 2015 American Transplant Congress

    Predictive Value of Cardiovascular Risk Assessment Tools in Kidney Transplantation

    C. Dunn, A. Holtzman, M. Hung, S. Greenstein.

    Surgery, Albert Einstein College of Medicine, Bronx, NY.

    Cardiovascular disease is a major cause of morbidity and mortality following kidney transplantation. Many cardiovascular risk screening tools have been developed, but they have never…
  • 2015 American Transplant Congress

    Conditioning of Mesenchymal Stromal Cells With mTOR Inhibitor Enhances Regenerative Properties of Secretome and Attenuates Vascular Calcification

    B. Hegner,1 C. Kurth,1 T. Schaub,1 C. Lange,2 D. Dragun.1

    1Clinic for Nephrology and Intensive Care Medicine, Charité University Hospital, Berlin, Germany; 2Department of Cell and Gene Therapy, University Medical Center Eppendorf, Hamburg, Germany.

    Similar to patients with chronic kidney disease, recipients of kidney transplants are a high-risk population for cardiovascular events due to arterial media calcification in particular…
  • 2015 American Transplant Congress

    Negative Exercise Myocardial Perfusion Scintigraphy Discards Silent Coronary Artery Disease in High Cardiovascular Risk Patients Awaiting for Kidney Transplantation

    E. Melilli,1 V. Navarro,2 O. Bestard,1 A. Gomez,3 J. Cruzado.1

    1Kidney Transplantation Unit, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; 2Nephrology Service, Hospital San Juan de Dios, San Jose, Costa Rica; 3Cardiac Intensive Care Unit, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

    Study Purpose:Screening for silent coronary artery disease (SCAD) in patients awaiting kidney transplantation is still controversial. Indeed, guidelines of some scientific societies show important discrepancies.…
  • 2015 American Transplant Congress

    Predicting Obstructive Coronary Artery Disease in Asymptomatic Renal Patients Undergoing Renal Transplantation

    D.-A. Moutzouris, C. Baker, A. Malaweera, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.

    Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    Almost 50% of asymptomatic patients with End Stage Renal Disease (ESRD) are reported to have significant flow-limiting coronary artery disease (CAD). Our practice involves a…
  • 2015 American Transplant Congress

    Progression of Coronary Artery Disease in High-Risk Patients Undergoing Renal Transplantation

    R. Corbett, N. Kumar, C. Baker, D. Moutzouris, M. Willicombe, J. Galliford, A. McLean, N. Duncan, D. Taube.

    Imperial College Renal and Transplant Centre, London, United Kingdom.

    Asymptomatic coronary artery disease [CAD] is common in patients with end-stage renal disease [ESRD]. While coronary revascularization prior to transplantation is associated with improved patient…
  • 2015 American Transplant Congress

    Longitudinal Assessment of Endothelial Function Following Kidney Transplantation

    C. Kensinger,1 G. Chen,2 A. Bian,2 T. Ikizler,3 K. Birdwell.3

    1Department of General Surgery, Vanderbilt University Medical Center, Nashville, TN; 2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN; 3Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN.

    Purpose:Evaluate the progression of endothelial function as a marker of cardiovascular disease following kidney transplant.Background:Endothelial dysfunction is associated with cardiovascular disease (CVD) in end stage…
  • 2015 American Transplant Congress

    Pretransplant Assessment of Vascular Calcification as a Risk Factor of Mortality, Graft Loss, and Cardiovascular Events in Renal Transplant Recipients

    P. Munguia, R. Caramelo, M. Rubio, L. Sahdalá, L. Arnaudas, J. Paul, á. Blasco, L. Lou, M. Aladren, A. Sanjuan, A. Gutierrez-Dalmau.

    Nephrology, Hospital Universitario Miguel Servet, Zaragoza, Spain.

    AIM: Cardiovascular events are the first cause of mortality in renal transplant recipients (RTRs), and their incidence is not only justified by the traditional CV…
  • 2015 American Transplant Congress

    Effect of Everolimus on Cardiovascular Parameters in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

    H. Holdaas,1 M. van der Giet,1 J. de Fijter,1 A. Speziale,2 C. Escrig,2 G. Junge,2 Z. Wang,3 J. Cruzado.1

    1For the ELEVATE Study, Oslo, Norway; 2Novartis, Basel, Switzerland; 3Novartis Corporation, East Hanover, NJ.

    Background: Long-term exposure to calcineurin inhibitors (CNIs) contributes to an unfavorable cardiovascular (CV) risk profile, including inferior renal allograft function and premature graft loss with…
  • 2015 American Transplant Congress

    The Role of Immunosuppression on Cardiac Functions of Kidney Transplant Recipients

    U. Cakir, O. Cavdaroglu, T. Erturk, E. Gurluler, A. Gurkan, I. Berber.

    Transplant Center, Acibadem University, Istanbul, Turkey.

    Cardiac disorders are associated with high morbidity and mortality in end-stage renal disease (ESRD).Kidney transplantation is known to increase the survival of dialysis patients by…
  • « Previous Page
  • 1
  • …
  • 1402
  • 1403
  • 1404
  • 1405
  • 1406
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences